AbbVie Announces Call for Entries for the AbbVie CF Scholarship for the 2019-2020 Academic School Year

- Scholarship awards $3,000 to 40 exceptional students living with cystic fibrosis (CF) for academic excellence, creativity and community involvement

- Top 40 students compete for public votes to receive one of two Thriving Student Scholarships for a total of $25,000 each

- Over $3 million in scholarships awarded to CF students to date through the CF Scholarship program

News provided by

AbbVie

Apr 17, 2019, 11:00 ET

NORTH CHICAGO, Ill., April 17, 2019 /PRNewswire/ -- AbbVie, a global research and development-based biopharmaceutical company, today announced that the AbbVie CF Scholarship program is now accepting applications for the 2019-2020 academic school year. Undergraduate and graduate students are invited to apply for the scholarship until May 29, 2019 at 11:00 a.m. U.S. eastern time by visiting www.AbbVieCFScholarship.com. Students can apply online or by downloading an application on the scholarship website.

"As a recipient of an AbbVie CF Scholarship, I hope that I can inspire other students living with CF to strive to be the best they can be," said Vinny Holmquist, 2018 recipient of the Thriving Undergraduate Scholarship. "Living with CF presented many challenges for me and my family, but it also motivated me to be a hard worker. I'm proud to say that the AbbVie CF Scholarship has enabled me to continue my education and has helped me pursue a degree in business administration."

Now in its 27^th year, the AbbVie CF Scholarship has awarded over $3 million in scholarships to students living with CF. The AbbVie CF Scholarship will award $3,000 scholarships to 40 exceptional students who demonstrate academic excellence, creativity and community involvement. Each of the 40 selected scholarship recipients will also be given the opportunity to compete for a total of $25,000 to use toward education-related expenses through one of two AbbVie CF Scholarship award categories: Thriving Undergraduate Student and Thriving Graduate Student.

AbbVie will announce the 2019 Thriving Undergraduate and Thriving Graduate Scholarship recipients this fall. The Thriving Undergraduate and Graduate Student Scholarships are granted based on a combination of exceptional academics, achievements and a creative presentation. These awards are also determined, in part, by public votes cast over a two-week voting period to be announced in the fall.

"Students living with CF are able to lead meaningful, impactful lives and make valuable contributions in their schools and local communities," said John Duffey, vice president, U.S. Specialty, AbbVie. "It's a privilege to recognize the amazing accomplishments of our AbbVie CF Scholarship recipients. We are proud to continue our commitment to these remarkable students."

The AbbVie CF Scholarship is part of the company's ongoing commitment to the CF community, which is comprised of more than 30,000 people in the United States. Today, more than half of the CF population is age 18 or older.¹For more information about the scholarship, please visit www.AbbVieCFScholarship.com.

About Cystic Fibrosis
Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and digestive system of those living with this condition.¹ In patients with CF, a thick, sticky mucus is produced in certain organs throughout the body, most commonly the lungs and digestive system. The mucus build-up in the lungs can cause difficulty breathing and may lead to life-threatening lung infections. In the digestive system, the thick mucus may prevent proper food digestion, potentially leading to malabsorption and malnutrition.

About the AbbVie CF Scholarship
The AbbVie CF Scholarship was established 27 years ago in recognition of the financial burdens many families touched by CF face and to acknowledge the achievements of students with CF. Since its inception, the scholarship program has awarded over $3 million in scholarships to over 1,000 students. The AbbVie CF Scholarship is part of AbbVie's ongoing commitment to the CF community, which is comprised of more than 30,000 people in the United States. As of 2016, more than half of the CF population are 18 years or older.¹

It is not necessary for scholarship applicants to have taken, currently take, or intend to take in the future, any medicine or product marketed by AbbVie, and this is not a consideration in the selection criteria. More information about the AbbVie CF Scholarship criteria and application can be found at www.AbbVieCFScholarship.com.

About AbbVie
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, LinkedIn or Instagram.

References

Cystic Fibrosis Foundation. About Cystic Fibrosis. Diagnosis and Genetics. Available at: https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/. Accessed February 2019.

SOURCE AbbVie